Skip to main content

Want a detailed portfolio tracker?

Arcutis Biotherapeutics (ARQT) P/E (2020 - 2026)

Arcutis Biotherapeutics (ARQT) P/E from Mar 31, 2020 to Jun 3, 2026. The TTM Arcutis Biotherapeutics (ARQT) P/E is -1.05K. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Arcutis Biotherapeutics (ARQT)

YearP/EChange
2026-1.05K+409.47%
2025-206.98+1686.28%
2024-11.59+681.90%
2023-1.48-71.23%
2022-5.15-48.88%
2021-10.08-37.63%
2020-16.16N/A

Comparison Arcutis Biotherapeutics (ARQT) P/E with competitors

Arcutis Biotherapeutics (ARQT) P/E is -1054.51.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.00%
NBYStablecoin Development Corp0.10-100.01%
ENLVEnlivex Therapeutics Ltd0.15-100.01%
FGENFibroGen Inc0.24-100.02%
TRAWTraws Pharma Inc0.47-100.04%
FBIOFortress Biotech Inc0.71-100.07%
CHRSCoherus Biosciences Inc0.98-100.09%
ORMPOramed Pharmaceuticals Inc1.47-100.14%
AGENAgenus Inc2.05-100.19%
VIVSVivoSim Labs Inc2.54-100.24%
INVAInnoviva Inc3.19-100.30%
CRMDCorMedix Inc3.65-100.35%
ABEOAbeona Therapeutics Inc4.20-100.40%
VXRTVaxart Inc4.26-100.40%
CVACCureVac N.V.4.45-100.42%
SRPTSarepta Therapeutics Inc4.62-100.44%
GLPGGalapagos NV4.86-100.46%
RIGLRigel Pharmaceuticals4.92-100.47%
ZVRAZevra Therapeutics Inc4.97-100.47%
ABUSArbutus Biopharma Corp5.69-100.54%
CGENCompugen Ltd7.38-100.70%
AUPHAurinia Pharmaceuticals Inc9.25-100.88%
ACADAcadia Pharmaceuticals Inc9.59-100.91%
OMEROmeros Corporation9.88-100.94%
PLXProtalix BioTherapeutics Inc9.91-100.94%
SPROSpero Therapeutics Inc10.73-101.02%
ADMAAdma Biologics Inc11.33-101.07%
SVASinovac Biotech Ltd11.44-101.08%
TBPHTheravance Biopharma Inc11.78-101.12%
HRMYHarmony Biosciences Holdings Inc12.18-101.16%
TGTXTG Therapeutics Inc13.18-101.25%
INCYIncyte Corp13.38-101.27%
SABSSAB Biotherapeutics Inc14.06-101.33%
XOMAXOMA Corp14.95-101.42%
REGNRegeneron Pharmaceuticals Inc14.98-101.42%
PBYIPuma Biotechnology Inc15.05-101.43%
EXELExelixis Inc15.79-101.50%
NAGENiagen Bioscience Inc16.35-101.55%
CPRXCatalyst Pharmaceuticals Inc17.34-101.64%
MDXGMimedx Group Inc17.38-101.65%
ARGXArgen X SE23.07-102.19%
HALOHalozyme Therapeutics Inc23.20-102.20%
XOMAOXOMA Corp25.34-102.40%
VRTXVertex Pharmaceuticals Inc25.66-102.43%
XOMAPXOMA Corp25.67-102.43%
CTMXCytomX Therapeutics Inc25.70-102.44%
ASNDAscendis Pharma A/S26.35-102.50%
RPRXRoyalty Pharma plc - Class A27.50-102.61%
SLNOSoleno Therapeutics Inc29.02-102.75%
LGNDLigand Pharmaceuticals Inc - Class B30.19-102.86%
BMRNBiomarin Pharmaceutical Inc37.51-103.56%
APLSApellis Pharmaceuticals Inc39.02-103.70%
KRYSKrystal Biotech Inc39.70-103.76%
GMABGenmab40.20-103.81%
ONCBeiGene Ltd67.03-106.36%
TECHBio-Techne Corp68.59-106.50%
VCELVericel Corp80.63-107.65%
PHARPharming Group N.V.87.74-108.32%
ALNYAlnylam Pharmaceuticals Inc124.93-111.85%
TLXTelix Pharmaceuticals Ltd139.89-113.27%
CORTCorcept Therapeutics Inc158.39-115.02%